Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      NPPA launches online grievance redressal helpline on orthopedic knee implants

      NPPA launches online grievance redressal helpline on orthopedic knee implants

      Ruby Khatun Khatun21 Aug 2017 2:00 PM IST
      New Delhi: Recently, National Pharmaceutical Pricing Authority (NPPA) had fixed the ceiling prices of orthopedic knee Implant systems. Now in this...
      Aurobindo to widen US portfolio, enter new markets in Europe

      Aurobindo to widen US portfolio, enter new markets in Europe

      Ruby Khatun Khatun21 Aug 2017 10:30 AM IST
      New Delhi: Aurobindo Pharma has said it would broaden product portfolio in the US while entering new markets in Europe as part of its growth strategy...
      Samsung Bioepis teams up with Takeda to develop original biotech drugs

      Samsung Bioepis teams up with Takeda to develop original biotech drugs

      Ruby Khatun Khatun21 Aug 2017 10:15 AM IST
      SEOUL: Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co...
      Amgen and Humana partner for improved health outcomes and efficiency

      Amgen and Humana partner for improved health outcomes and efficiency

      Ruby Khatun Khatun21 Aug 2017 10:00 AM IST
      THOUSAND OAKS, Calif. and LOUISVILLE: Two of the nation's leading health organizations, health and well-being company Humana Inc. and biotechnology...
      Bristol-Myers kidney cancer drug fails late-stage trial

      Bristol-Myers kidney cancer drug fails late-stage trial

      Ruby Khatun Khatun21 Aug 2017 9:45 AM IST
      Bristol-Myers Squibb Co said on Tuesday its combination drug to treat previously untreated patients with advanced or metastatic renal cell carcinoma,...
      Aurobindo Pharma Q1 net profit down 11 percent at Rs 518 crore

      Aurobindo Pharma Q1 net profit down 11 percent at Rs 518 crore

      Ruby Khatun Khatun20 Aug 2017 10:15 AM IST
      New Delhi: Aurobindo Pharma Ltd reported an 11.38% decline in consolidated net profit at Rs 518.33 crore for the first quarter ended 30 June 2017.The...
      DoP released FAQs on GST on drugs and Pharmaceuticals, check out details

      DoP released FAQs on GST on drugs and Pharmaceuticals, check out details

      Ruby Khatun Khatun20 Aug 2017 10:09 AM IST
      Since the implementation, Goods and Services Tax (GST), confusion has been created at almost all levels of the distribution chains of the pharma...
      Suven Life secures process patents for neuro-degenerative drug

      Suven Life secures process patents for neuro-degenerative drug

      Ruby Khatun Khatun20 Aug 2017 10:00 AM IST
      HYDERABAD: Suven Life Sciences Ltd (Suven) announces that the grant of one process patent from Europe, one process patent from Japan and one process...
      FDA expands use of AstraZeneca, Merck ovarian cancer drug

      FDA expands use of AstraZeneca, Merck ovarian cancer drug

      Ruby Khatun Khatun20 Aug 2017 10:00 AM IST
      The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing...
      LifeCell launches improved and advanced umbilical cord stem cell collection kit

      LifeCell launches improved and advanced umbilical cord stem cell collection kit

      Ruby Khatun Khatun20 Aug 2017 9:45 AM IST
      CHENNAI: Most expectant parents draw a checklist of things that need to be taken to the hospital at the time of delivery. The most important thing out...
      Bayer, Johnson and Johnson win third US trial over Xarelto bleeding risk

      Bayer, Johnson and Johnson win third US trial over Xarelto bleeding risk

      Ruby Khatun Khatun20 Aug 2017 9:30 AM IST
      A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the...
      Cigna to increase stake in Cigna TTK JV to 49 percent

      Cigna to increase stake in Cigna TTK JV to 49 percent

      Ruby Khatun Khatun20 Aug 2017 9:15 AM IST
      Mumbai: Private health insurer Cigna TTK filed an application with the Insurance Regulatory and Development Authority of India (IRDAI) to increase...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok